Vergleich

Recombinant Human Proprotein convertase subtilisin/kexin type 9(PCSK9)

ArtNr CSB-AP005741HU-10
Hersteller Cusabio
Menge 10ug
Kategorie
Typ Proteins Recombinant
Specific against Human
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Lieferbar
Classification
Other Recombinant Protein
Subdivision
Others
Research Areas
Cardiovascular
Uniprot NO.
Q8NBP7
Gene Names
PCSK9
Source
Mammalian cell
Expression Region
31-152aa & 153-692aa
Sequence
QEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFH RCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQA QAARRGYLTKILHVFHGLLPGFLVKMSGDLLELAL KLPHVDYIEEDSSVFAQ & SIPWNL
ERITPPRY RADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVM VTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSG RDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFI RKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLAR AGVVLVTAAGNFRDDACLYSPASAPEVITVGATNA QDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSDCS TCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAEL RQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPP STHGAGWQLFCRTVWSAHSGPTRMATAVARCAPDE ELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFG GEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVH CHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPN QCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQ VTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVV RSRDVSTTGSTSEGAVTAVAICCRSRHLAQASQEL
Protein Description
Full Length
Tag Info
C-terminal Avi-tagged
Mol. Weight
14 & 59 kDa
Biological Activity
The ED50 as determined by its ability to bind Human LDLR in functional ELISA is less than 200 ug/ml
Purity
Greater than 95% as determined by SDS-PAGE.
Endotoxin
Less than 1.0 EU/ug as determined by LAL method.
Storage Buffer
0.2 um Filtered 50 mM HEPES, 150 mM NaCl, 20% Glycerol, pH 7.4
Alias
Proprotein Convertase Subtilisin/Kexin Type 9; Neural Apoptosis-Regulated Convertase 1; NARC-1; Proprotein Convertase 9; PC9; Subtilisin/Kexin-Like Protease PC9; PCSK9; NARC1
Relevance
Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER , the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2), and play a role in the neural development.
Function
Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members
Involvement in disease
Hypercholesterolemia, autosomal dominant, 3 (HCHOLA3)
Subcellular Location
Cytoplasm, Secreted, Endosome, Lysosome, Cell surface, Endoplasmic reticulum, Golgi apparatus
Protein Families
Peptidase S8 family
Tissue Specificity
Expressed in neuro-epithelioma, colon carcinoma, hepatic and pancreatic cell lines, and in Schwann cells.
Paythway
Cholesterolmetabolism

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 10ug
Lieferbar: Out of stock
Fragen zum Produkt?
 
Schließen